Leading Edge Technology for Pathogen Detection
Leading-Edge Technologies to Detect Aerosolized Pathogens
- Signed Options Agreement: Technology developed by WashU that immediately detects SARS-CoV-2 and other pathogens in people and spaces
- Funded research: Through NIH RADx Initiative Grant
- Purpose: Create biosensors that substantially reduce large-scale infectious disease testing times and improves aerosolized pathogen detection accuracy in indoor spaces
September 19, 2021 - Announcement Pathogen Detectors: Y2X Life Sciences and a team of Professors at Washington University, St. Louis (WashU) have developed pathogen…
Company obtains rights from Washington University, St. Louis to develop cutting-edge biosensor technologies for monitoring air quality and the presence of infectious disease in…
Y2X Life Sciences actively engages in groundbreaking research and development for disrupting the transmission of infectious diseases.
The result is innovative technologies that bring about faster recoveries from pandemics like Covid-19, and have the potential to limit the scope and spread of future pandemics and epidemics.